key: cord-0849198-s3razs4z
authors: Wu, Yanyan; Ma, Zhuang; Guo, Xiaozhong; Li, Hongyu; Tang, Yufu; Meng, Hao; Yu, Hao; Peng, Chengfei; Chu, Guiyang; Wang, Xinwei; Teng, Yue; Zhang, Quanyu; Zhu, Tianyi; Wang, Bing; Tong, Zhenhua; Zhao, Haitao; Lu, Hui; Qi, Xingshun
title: Clinical characteristics and outcomes of COVID-19 patients with hypoxic hepatitis
date: 2021-03-04
journal: Clin Res Hepatol Gastroenterol
DOI: 10.1016/j.clinre.2021.101665
sha: 8ca592791afea0fcf3fa1bb1cf463521f375b4a9
doc_id: 849198
cord_uid: s3razs4z

nan

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Liver injury is a common extrapulmonary manifestation of coronavirus disease 2019 (COVID-19) with an incidence of 37%-53% [1] [2] [3] . Liver injury can be manifested as mild to moderate elevation of transaminases levels, and even fulminant liver failure [4] . Major causes of COVID-19-associated liver injury probably include viral infection itself, systemic inflammatory response, hypoxic injury, druginduced liver injury, and exacerbation of pre-existing liver disease. Hypoxic hepatitis is a lifethreatening type of liver injury with a short-term mortality of 45-72% [5] . Until now, the information regarding hypoxic hepatitis in COVID-19 patients has been scarcely reported [1, 2] .

All researchers work at the General Hospital of Northern Theater Command in Shenyang, and a majority of them volunteered to participate in the clinical management of COVID-19 patients at the Huoshenshan hospital in Wuhan from February 2020 to April 2020. Diagnosis and severity of COVID-19 were in accordance with the Chinese practice guidelines [6] . A confirmed case of COVID-19 was defined as a positive result on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleic acid in samples of sputum, nasopharynx swab, and secretions of lower respiratory tract tested by realtime reverse-transcriptase-polymerase-chain reaction (rRT-PCR) assay. Severe case was defined as : 1) shortness of breath, respiration rate ≥30 times/minute; 2) oxygen saturation ≤93% in the resting state;

or 3) partial pressure of oxygen/fraction of inspired oxygen ≤300mmHg. Critical case was defined as: 1) respiratory failure requiring mechanic ventilation; 2) other organ failure requiring intensive care unit (ICU) management; or 3) shock.

In the present study, we retrospectively reviewed the medical records of 3041 COVID-19 patients who were consecutively admitted to the Huoshenshan hospital, and then identified 8 COVID-19 patients with a high suspicion of hypoxic hepatitis, but without previous history of hepatobiliary diseases.

Hypoxic hepatitis should meet the following criteria [7] : 1) underlying diseases, such as cardiac failure, respiratory failure, or shock; 2) a rapid increase of serum aminotransferase by more than 20 times the upper limit of normal (ULN); and 3) exclusion of other causes of liver injury. We collected the information regarding demographic data (i.e., age and gender), comorbidities (i.e., diabetes, coronary heart disease, and hypertension), clinical presentations, severity of COVID-19 at admission, laboratory tests [i.e., alanine aminotransferase (ALT) and aspartate aminotransferase ( The median age of the 8 COVID-19 patients was 68 (range: 65-81) years old, and 4 (50%) of them were male. Three patients had diabetes, 4 hypertension, 2 cardiovascular disease, and 1 chronic respiratory disease. At admission, 6 and 4 patients presented with cough and fever, respectively; 2 and ventilation. All patients were admitted/transferred to ICU with a median ICU duration of 20.5 (range: days. Only 1 (12.5%) patient was discharged, and 7 (87.5%) died. At admission, 3 (37.5%) patients had mildly increased serum aminotransferase levels, of whom 1 had an increased AST level of 57.8 IU/L, and 3 had an increased ALT level of 42.4-65.6 IU/L; and the remaining 5 patients had normal AST level of 22.5-38.7 IU/L and ALT level of 20.8-26.2 IU/L. During hospitalizations, serum aminotransferase levels were sharply increased beyond 20 times the ULN within a median duration of 1.5 (range: 1-7) days after respiratory failure, cardiac failure, and/or shock (Figure 1) . Five patients died at the same time of peak ALT/AST level (cases 1, 4, 5, 6 and 7), 2 died within 6 days after AST and ALT levels became nearly normal (cases 2 and 3), and 1 discharged within 

Conceptualization: Xingshun Qi

All authors have made an intellectual contribution to the manuscript and approved the submission

The liver injury and gastrointestinal symptoms in patients with Coronavirus Disease 19: A systematic review and meta-analysis

Liver function test abnormalities are associated with a poorer prognosis in Covid-19 patients: Results of a French cohort

Incidence, risk factors, and prognosis of abnormal liver biochemical tests in COVID-19 patients: a systematic review and meta-analysis

Severe liver failure during SARS-CoV-2 infection

Liver international : official journal of the International Association for the Study of the

General Office of National Health Commission of the People's Republic of China. Diagnosis and treatment of corona virus disease-19

Hypoxic hepatitis: a challenging diagnosis

Amelioration of liver injury by ischaemic preconditioning

Relationship between hypoxic hepatitis and cor pulmonale in patients treated in the respiratory ICU

Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan

We are indebted to all of the medical staffs who volunteered to participate in the treatment of COVID-19 patients at the Wuhan Huoshenshan Hospital. We would like to appreciate our study team for collecting the data of including Ruirui Feng, Yang An, Li Luo, Yiyan Zhang, Haijuan, Yao, Fangfang Yi, and Hongxin Chen. J o u r n a l P r e -p r o o f

2963013648@qq.com (YW) Availability of data and material: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.